반응식
C[O:2][C:3]1[CH:12]=[C:11]2[C:6]([C:7]([NH:13][CH2:14][C:15]3[N:19]4[N:20]=[C:21]([C:24]5[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=5)[CH:22]=[CH:23][C:18]4=[N:17][N:16]=3)=[CH:8][CH:9]=[N:10]2)=[N:5][CH:4]=1.[OH-].[Na+]>Br.C(Cl)Cl.O>[C:24]1([C:21]2[CH:22]=[CH:23][C:18]3[N:19]([C:15]([CH2:14][NH:13][C:7]4[CH:8]=[CH:9][N:10]=[C:11]5[C:6]=4[N:5]=[CH:4][C:3]([OH:2])=[CH:12]5)=[N:16][N:17]=3)[N:20]=2)[CH:25]=[CH:26][CH:27]=[CH:28][CH:29]=1참가 물질
반응물 2
생성물 1
시약·촉매·용매 3
반응 조건
- 온도
- 100 °C
실험 절차
In a 25 mL sealed tube was dissolved 7-methoxy-N-((6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)-1,5-naphthyridin-4-amine (prepared according to General Method D) (300 mg, 782 μmol) in 5 mL of concentrated HBr then stirred and heated at 100° C. for 48 h. The reaction mixture was diluted with DCM and H2O then neutralized with NaOH (1N) to neutral pH. The aqueous phase was extracted 3× with DCM then the organic layer was dried over Na2SO4, filtered and concentrated under reduced pressure. The crude mixture was purified by MPLC (ISCO) with DCM:MeOH:NH4OH (90:10:1) and then triturated with hot EtOH to afforded 8-((6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methylamino)-1,5-naphthyridin-3-ol (230 mg, 79.6% yield) as a tan solid. MS m/z=369.1 [M+1]+. Calc'd for C20H15N7O: 370.0.
후처리
- customIn a 25 mL sealed tube
- extractionThe aqueous phase was extracted 3× with DCM
- dry with materialthe organic layer was dried over Na2SO4
- filtrationfiltered
- concentrationconcentrated under reduced pressure
- customThe crude mixture was purified by MPLC (ISCO) with DCM:MeOH:NH4OH (90:10:1)
- customtriturated with hot EtOH
출처 및 근거
- ORD 기록
- ord-714b8669e38148cba449a210b136e739
- 출처 데이터셋
- uspto-grants-2012_06
- 특허 번호
- US08198448B2
연결된 노트
불러오는 중…